DE60336927D1 - - Google Patents

Info

Publication number
DE60336927D1
DE60336927D1 DE60336927T DE60336927T DE60336927D1 DE 60336927 D1 DE60336927 D1 DE 60336927D1 DE 60336927 T DE60336927 T DE 60336927T DE 60336927 T DE60336927 T DE 60336927T DE 60336927 D1 DE60336927 D1 DE 60336927D1
Authority
DE
Germany
Prior art keywords
provides
forms
cyprinus
carpino
vaccination
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60336927T
Other languages
German (de)
English (en)
Inventor
Moshe Kotler
Ayana Benet
Izhak Bejerano
Nissim Chen
Marina Hutoran
Ariel Ronen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MINISTRY OF AGRICULTURAL AND RURAL DEV Department OF FISHERIES AND AQUACULTURE
Yissum Research Development Co of Hebrew University of Jerusalem
Original Assignee
MINISTRY OF AGRICULTURAL AND RURAL DEV Department OF FISHERIES AND AQUACULTURE
Yissum Research Development Co of Hebrew University of Jerusalem
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MINISTRY OF AGRICULTURAL AND RURAL DEV Department OF FISHERIES AND AQUACULTURE, Yissum Research Development Co of Hebrew University of Jerusalem filed Critical MINISTRY OF AGRICULTURAL AND RURAL DEV Department OF FISHERIES AND AQUACULTURE
Application granted granted Critical
Publication of DE60336927D1 publication Critical patent/DE60336927D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/00021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/00034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/00061—Methods of inactivation or attenuation
    • C12N2710/00064—Methods of inactivation or attenuation by serial passage
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/01—DNA viruses
    • G01N2333/03—Herpetoviridae, e.g. pseudorabies virus

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Fodder In General (AREA)
  • Feed For Specific Animals (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DE60336927T 2003-01-01 2003-12-22 Expired - Lifetime DE60336927D1 (https=)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IL15377503A IL153775A0 (en) 2003-01-01 2003-01-01 Immunizing fish against viral infection
PCT/IL2003/001097 WO2004061093A1 (en) 2003-01-01 2003-12-22 Immunizing fish against viral infection

Publications (1)

Publication Number Publication Date
DE60336927D1 true DE60336927D1 (https=) 2011-06-09

Family

ID=29798413

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60336927T Expired - Lifetime DE60336927D1 (https=) 2003-01-01 2003-12-22

Country Status (12)

Country Link
US (1) US7351527B2 (https=)
EP (1) EP1578959B1 (https=)
JP (2) JP4690049B2 (https=)
CN (1) CN100535108C (https=)
AT (1) ATE507286T1 (https=)
AU (1) AU2003288510A1 (https=)
DE (1) DE60336927D1 (https=)
DK (1) DK1578959T3 (https=)
IL (2) IL153775A0 (https=)
PL (1) PL209978B1 (https=)
RU (1) RU2369635C2 (https=)
WO (1) WO2004061093A1 (https=)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5109114B2 (ja) * 2006-02-24 2012-12-26 国立大学法人三重大学 魚類抗体産生の新規検出法
WO2007119279A1 (ja) * 2006-04-13 2007-10-25 National University Corporation Tokyo University Of Marine Science And Technology コイヘルペスウイルス（ｋｈｖ）病用ｄｎａワクチン
JP5567244B2 (ja) * 2006-06-06 2014-08-06 共立製薬株式会社 魚類ストレプトコッカス・ディスガラクティエを抗原とする不活化ワクチン
BRPI0816134A2 (pt) * 2007-08-28 2015-07-28 Université de Liège Herpesvírus, sequência de dna, vetor, célula, vírus, método para produção de partículas infecciosas, partículas infecciosas, vacina, uso de herpesvírus ou da sequência de dna ou do vetor ou das partículas infecciosas, e, método para o tratamento preventivo e/ou terapêutico de uma doença.
EP2031065A1 (en) * 2007-08-28 2009-03-04 Université de Liège A recombinant koi herpesvirus (KHV) or Cyprinid herpesvirus 3 (CyHV-3) and a vaccine for the prevention of a disease caused by KHV/CyHV-3 in Cyprinus carpio carpio or Cyprinus carpio koi
JP2010143860A (ja) * 2008-12-19 2010-07-01 Chisso Corp タンパク質の安定化剤
JP5462518B2 (ja) * 2009-04-09 2014-04-02 公益財団法人ヒューマンサイエンス振興財団 抗体精製方法
EP2487241A1 (en) 2011-02-09 2012-08-15 Westfälische Wilhelms-Universität Münster RNAi agents and compositions useful as carp therapeutics
EP2797627B1 (en) * 2011-12-30 2020-10-07 Gesval s.a. A recombinant koi herpesvirus (khv) and vaccine for the prevention of a disease caused by khv
CA2905257C (en) * 2013-03-15 2022-03-15 Atlantium Technologies Ltd. System and method for inactivation of infectious pancreatic necrosis virus (ipnv) using optimized ultraviolet (uv) light
JP6406703B2 (ja) * 2013-05-15 2018-10-17 国立研究開発法人水産研究・教育機構 コイ科ヘルペスウイルス−２（Ｃｙｐｒｉｎｉｄｈｅｒｐｅｓｖｉｒｕｓ−２：ＣｙＨＶ−２）感染症用ワクチンおよびその製造方法、ならびにＣｙＨＶ−２ウイルス製造方法
CN103430936A (zh) * 2013-09-06 2013-12-11 中国水产科学研究院黑龙江水产研究所 一种用于鱼类基因组dna提取的鱼鳍组织的制备方法
IL230970A0 (en) * 2014-02-13 2014-09-30 Univ Ramot Tilapia virus vaccines
CN104774802B (zh) * 2015-04-27 2017-12-08 上海海洋大学 银鲫鱼背鳍细胞系
RU2640346C1 (ru) * 2016-08-11 2017-12-27 Федеральное государственное бюджетное образовательное учреждение высшего образования "Государственный аграрный университет Северного Зауралья" (ФГБОУ ВО ГАУ Северного Зауралья) Способ антиоксидантной защиты мальков карпа
EP3897703A2 (en) 2018-12-21 2021-10-27 Intervet International B.V. Serum free intracellular pathogen vaccine

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5780448A (en) * 1995-11-07 1998-07-14 Ottawa Civic Hospital Loeb Research DNA-based vaccination of fish

Also Published As

Publication number Publication date
AU2003288510A8 (en) 2004-07-29
EP1578959A1 (en) 2005-09-28
AU2003288510A1 (en) 2004-07-29
ATE507286T1 (de) 2011-05-15
DK1578959T3 (da) 2011-08-15
JP2011024584A (ja) 2011-02-10
RU2369635C2 (ru) 2009-10-10
IL153775A0 (en) 2003-07-31
WO2004061093A1 (en) 2004-07-22
US20060013828A1 (en) 2006-01-19
JP2006512078A (ja) 2006-04-13
EP1578959B1 (en) 2011-04-27
CN1742083A (zh) 2006-03-01
IL169412A (en) 2011-04-28
PL376441A1 (en) 2005-12-27
US7351527B2 (en) 2008-04-01
JP4690049B2 (ja) 2011-06-01
PL209978B1 (pl) 2011-11-30
CN100535108C (zh) 2009-09-02
RU2005120158A (ru) 2006-01-20

Similar Documents

Publication Publication Date Title
DE60336927D1 (https=)
DE602004020189D1 (de) Adjuvante influenza-vakzine
TW200806316A (en) Yeast-based vaccine for inducing an immune response
WO2004080403A3 (en) Influenza virus vaccine
WO2018140766A3 (en) Porcine coronavirus vaccines
WO2006068663A3 (en) Vaccine compositions for treating coronavirus infection
EP1917033A4 (en) VIRUS LIKE PARTICLES AS PARAMYXOVIRUS VACCINES
ATE451119T1 (de) Untereinheit-impfstoff gegen das respiratorische synzytialvirus
EP1220925B8 (en) Chlamydia antigens and corresponding dna fragments and uses thereof
PT1409692E (pt) Novos péptidos do derivados da proteína g do vírus respiratório sincicial (vrs) e sua utilização numa vacina
DE60115051D1 (de) Immunologische adjuvans verbindungen
DE60222296D1 (de) Impfstoff von umhüllten viren und verfahren zu seiner herstellung
NO20020615L (no) Vaksine
ATE494377T1 (de) Vakzine gegen ipnv die aus hefezellen isoliert werden
WO2003103570A3 (en) Transcutaneous immunization against papillomavirus with papillomavirus virus-like particles
UA86405C2 (ru) Способ вакцинации против инфекции семенников, вызванной вирусом бычьей вирусной диареи
TW200634156A (en) Neutralizing epitope-based growth enhancing vaccine
ATE353226T1 (de) Adjuvanszusammensetzung enthaltend fha oder ein fha-fragment in freier form
ATE424844T1 (de) Kombinationsvakzine für geflügel
MY191101A (en) Protein from photobacterium damselae and use thereof
WO2004073604A3 (en) Dna vaccines that express an adp-ribosyltransferase toxin devoid of adp-ribosyltransferase activity
BRPI0604365A (pt) polipeptìdeo isolado, composição de vacina anti-carrapato de múltiplas espécies, e, uso dos mesmos
HUP0402548A2 (hu) Madárembrió-részecskékből álló biomassza vírusantigének előállítására
WO2002096940A3 (en) Attenuated very virulent infectious bursal disease virus
UA33502A (uk) Спосіб виготовлення інактивованої вакцини проти сальмонельозів тварин